A very-high-purity von Willebrand factor preparation containing high-molecular-weight multimers

Vox Sanguinis

Volumn 76, Issue 2, 1999, Pages 85-89

  Barington, Karina Alsoe ^a,b   Kærsgaard, Per ^a  

^a HemaSure A/S   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; COLLAGEN; POLYMER; VON WILLEBRAND FACTOR;

ARTICLE; CHROMATOGRAPHY; DRUG ACTIVITY; DRUG MANUFACTURE; DRUG PROTEIN BINDING; DRUG PURIFICATION; DRUG PURITY; GEL FILTRATION; ION EXCHANGE; MOLECULAR WEIGHT; PLASMA; PRIORITY JOURNAL; VIRUS INACTIVATION;

EID: 0033049994     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031026     Document Type: Article

References (15)

1. Perret BA, Furlan M, Beck EA: Studies on factor VIII-related protein. II. Estimation of molecular size differences between factor VIII oligomers. Biochim Biophys Acta 1979;578: 164-174.
2. Sixma JJ, Sakariassen KS, Beeser-Visser NH, Ottenhof-Rovers M, Bolhuis PA: Adhesion of platelets to human artery subendothelium: Effect of factor VIII-von Willebrand factor of various multimeric compositions. Blood 1984; 63:128-139.
3. Mannucci PM: Biochemical characteristics of therapeutic plasma concentrates used in the treatment of von Willebrand disease. Haemostasis 1994;24:285-288.
4. Mannucci PM, Lattuada A, Ruggeri ZM: Proteolysis of von Willebrand factor in therapeutic plasma concentrates. Blood 1994;83:3018-3027.
5. Baillod P, Affolter B, Kurt GH, Pflugshaupt R: Multimeric analysis of von Willebrand factor by vertical sodium dodecyl sulphate agarose gel electrophoresis, vacuum blotting technology and sensitive visualization by alkaline phosphatase anti-alkaline phosphatase complex. Thromb Res 1992;66:745-755.
6. Märki HH: Blood - plasma proteins; in Lentner C (ed): Geigy Scientific Tables. Basel, Ciba-Geigy, 1984, vol 3, pp 135-162.
7. Brown JE, Bosak JO: An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 1986;43:303-311.
8. Schoppmann A, Weber A, Hondl F, Linnau Y: Factor VIII concentrate: What is 'high purity'? Thromb Haemost 1994;72:481-490.
9. Kærsgaard P, Barington KA: Isolation of the factor VIII-von Willebrand factor complex directly from plasma by gel filtration. J Chromatogr B 1998;715:357-367.
10. Ruggeri ZM, Ware J: von Willebrand factor. FASEB J 1993;7:308-316.
11. Chang P, Aronson DL: Plasma derived von Willebrand factor preparations: Collagen binding and ristocetin cofactor activities. Thromb Haemost 1997;78:930-933.
12. Favaloro EJ, Dean M, Grispo L, Exner T, Koutts J: von Willebrand's disease: Use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy. Am J Hematol 1994;45:205-211.
13. 2+ Proc Natl Acad Sci USA 1973;70:2326-2329.
14. Prince AM, Horowitz B, Brotman B: Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate. Lancet 1986;i:706-710.
15. Hart HF, Hart WG, Crossley J, Perric A-M, Wood DJ, John A, McOmish F: Effect of terminal (dry) heat treatment on non-enveloped viruses in coagulation factor concentrates. Vox Sang 1994;67:345-350.